June 13, 2016 – Just before World Blood Donor Day, June 14, the worst mass shooting in U.S. history demonstrates the importance of a stable community blood supply in response to disasters. While a call went out to immediately replenish the blood supply in the Orlando area, blood donated by people more than a day in advance of the tragedy was necessary to sustain life during medical treatment.
“We are deeply saddened and our sympathy goes out to those affected. The tragedy is a harsh reminder of the importance of blood donors that give in advance of the need. It takes more than 100 blood donors every day to provide blood in this community for daily patient needs and to be prepared for disasters. We welcome and are grateful for all blood donors, and encourage anyone eligible to donate on a regular basis,” says Tina Hooper, spokesperson for LifeShare Blood Centers.
The first 24 to 48 hours after blood is donated, it is put through several tests and processed prior to being available for patient use. Approximately 38 percent of the U.S. population is eligible to donate blood. With only six percent being blood donors, shortages in blood supply occur periodically.
LifeShare Blood Centers is joining with blood banks across the world to publicly honor blood donors in conjunction with the World Health Organization (WHO) World Blood Donor Day on June 14. The theme of World Blood Donor Day 2016 is “Blood Connects Us All.”
On June 14, LifeShare Blood Centers invites all blood donors to stop by any of their locations and enjoy international snacks in their honor for World Blood Donor Day.
For more information and to see blood center locations and hours visit http://www.lifeshare.org/.
LifeShare Blood Centers regularly supplies blood components to 117 medical facilities throughout Louisiana, East Texas and South Arkansas. Founded in Shreveport, La. in 1942, where its headquarters remain, it is a nonprofit community service provider governed by a volunteer Board of Trustees. LifeShare is a member of America’s Blood Centers and the American Rare Donor Program, is licensed by the U.S. Food & Drug Administration and accredited by AABB.